Back to Top Skip to main content Skip to sub-navigation

Applying COVID-19 innovations to the future of MHS medicine

Virtual health visits are expanding in response to COVID-19. Virtual health visits are expanding in response to COVID-19.

Recommended Content:

Coronavirus | Research and Innovation

“I would do anything to help my patients” and “I look forward to business as usual after COVID-19” – declarations many Military Health System providers worldwide would wholeheartedly agree with during the coronavirus pandemic. We give our best every day to ensure infected and non-infected alike get the treatment they need.

As we envision health care in a post-pandemic world, we can’t ignore that COVID-19 has already irrevocably changed how we deliver care and will continue to do so. We must use the terrible clarity these unprecedented circumstances provide to honestly evaluate our tools and practices, and apply that wisdom to make real, lasting improvements to health care.

This mindset of embracing innovation for the sake of our patients is already a hallmark of MHS providers. We find creative, clinically sound ways to treat our patients no matter the obstacle.

We are also in a prime position to lead by example in keeping the best of what we’re learning during COVID-19. The MHS is one of the largest health care systems in the world and has the tools, experience, logistical capacity and operational flexibility to do what many other health systems cannot. Our experience with global, 24/7, life-and-death medical crises means we can lead in innovation when it’s most needed.

A MHS health care provider holds a virtual health visit with a patient.
A MHS health care provider holds a virtual health visit with a patient. 

Case in Point: Virtual Health

One way MHS providers can start adopting innovative practices right now during COVID-19 is through virtual health, also known as telehealth or telemedicine. The MHS offers ready-to-use virtual health capabilities that are effective, secure, accessible and compliant. In fact, the MHS Virtual Medical Center (VMC) has rapidly expanded scalable virtual health tools for military patients and medical personnel across the Services to ensure continuity of care during the COVID-19 pandemic.   

The VMC serves as a hub for virtual health, enabling medical personnel in the field to connect with patients. It provides operational experience in delivering care around the world, working across international time zones, specialties and military service branches to get the right treatment to the right patient at the right time. The VMC is uniquely prepared to help providers and patients understand and use virtual health.

Working with the VMC allows providers to hit the ground running with tested tools and easy access to subject matter experts and training. The VMC workflows also efficiently connect providers with patients. Once they use virtual health, many providers find that they can do many appointments through a virtual health platform, with greater convenience and satisfaction for both them and their patients.

Extensive Resources

The resources available right now for incorporating virtual health into your practice include:

  • The VMC: Any MHS provider or care team can request access to military virtual health platforms by accessing the VMC SharePoint site.
  • Telemedicine Privileging:It is permissible for most MHS providers (to include personal services contract providers) to virtually care for patients located in a different state during COVID-19. Virtual care can occur outside a military medical treatment facility (MTF), such as at a patient’s home. A unique advantage for military medical personnel is that you can both be credentialed at your local facility and have privileges at the VMC. This pairing enables you to virtually access patients and their electronic health records at any MTF worldwide, a huge force multiplier.
  • Your local MTF: Talk to your local MTF virtual health point of contact. If your MTF does not have one yet, the VMC can connect you to experts.
  • ADVISOR Help Line: The Advanced Virtual Support for Operational Forces system, or ADVISOR, provides on-demand telephone and secure video consultations with specialty providers during emergencies. Originally designed for field personnel, ADVISOR now enables any MTF to get 24/7 live help with COVID-19 cases. Operators route calls to on-call MHS providers with operational experience in:
  • Infectious disease (pediatric/adult)
  • Palliative care
  • Critical care (pediatric/adult)

Remembering for the Future

Virtual health is undeniably different from traditional practice and can take getting used to. The technological, logistical and even cultural hurdles we encounter in adopting it – or any new practice born of crisis – are worth overcoming to help ensure patients receive the care they need anytime, anywhere.

That is especially important to remember once things return to “the new normal.” One of the biggest mistakes we can make when a crisis abates is to forget why we needed to change in the first place, and to think that those changes applied just to that situation instead of informing our practice going forward.

Virtual health is going to be part of that future, to the point that in five years, we won’t be saying virtual health or telemedicine, just -- medicine.

We need to learn from our COVID-19 experience and change our tools, processes and workflows as needed so we are better prepared for all world-changing incidents, not just the next pandemic. If we do, we will show that when we say “we’ll do anything for our patients,” we really mean it.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA-PI 3200.01: Research and Development (R&D) Enterprise Activity (EA)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity. b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable. c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a). d. Supports the following objectives of the R&D EA: (1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight. (2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives. (3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions. (4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

Showing results 1 - 12 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.